Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Bolt Biotherapeutics Inc. (BOLT)

3.63   -0.13 (-3.46%) 01-21 18:26
Open: 3.69 Pre. Close: 3.76
High: 3.8126 Low: 3.48
Volume: 169,133 Market Cap: 135M
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; and BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers. It is also developing programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood city, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.815 - 3.838 3.838 - 3.855
Low: 3.427 - 3.455 3.455 - 3.475
Close: 3.592 - 3.634 3.634 - 3.664

Technical analysis

as of: 2022-01-21 4:25:13 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.25     One year: 6.03
Support: Support1: 3.43    Support2: 2.85
Resistance: Resistance1: 4.50    Resistance2: 5.16
Pivot: 4.00
Moving Average: MA(5): 3.79     MA(20): 4.16
MA(100): 9.93     MA(250):
MACD: MACD(12,26): -0.65     Signal(9): -0.78
Stochastic oscillator: %K(14,3): 21.19     %D(3): 22.22
RSI: RSI(14): 34.14
52-week: High: 43.07  Low: 3.43  Change(%): -88.7
Average Vol(K): 3-Month: 391  10-Days: 273

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BOLT has closed above bottom band by 27.2%. Bollinger Bands are 60.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to Bolt Biotherapeutics Inc.'s normal range. The bands have been in this narrow range for 18 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 06 Jan 2022
Bolt Biotherapeutics Doses First Patient with BDC-1001 in - GlobeNewswire

Fri, 19 Nov 2021
Bolt Biotherapeutics Announces Changes to its Board of Directors - GlobeNewswire

Fri, 12 Nov 2021
Bolt Biotherapeutics Presents New Preclinical Data on Three - GlobeNewswire

Fri, 01 Oct 2021
Bolt Biotherapeutics to Present Updates on Three Pipeline Programs - GlobeNewswire

Thu, 30 Sep 2021
Our First Look At Bolt Biotherapeutics - Seeking Alpha

Wed, 08 Sep 2021
Bolt Biotherapeutics Announces Clinical Collaboration with Bristol Myers Squibb to Study BDC-1001 in Combination with Opdivo® for Treatment of HER2-Expressing Solid Tumors - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 37
Shares Float (M) 13
% Held by Insiders 6.67
% Held by Institutions 94.87
Shares Short (K) 4,200
Shares Short P. Month (K) 4,360

Stock Financials

EPS -4.199
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 7.380
Profit Margin
Operating Margin -10988.70
Return on Assets (ttm) -26.1
Return on Equity (ttm) -64.7
Qtrly Rev. Growth
Gross Profit (p.s.) -1.076
Sales Per Share 0.020
EBITDA (p.s.) -2.188
Qtrly Earnings Growth
Operating Cash Flow (M) -52
Levered Free Cash Flow (M) -41

Stock Valuations

PE Ratio -0.86
PEG Ratio
Price to Book value 0.49
Price to Sales 179.96
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.